Xenotransplants - ML Laboratories
Latest Information Update: 24 Apr 2003
At a glance
- Originator ML Laboratories
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Xenotransplant rejection